Security key
221015100
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 30,026,264
- Share change
- +2,389,593
- Total reported value
- $158,538,176
- Put/Call ratio
- 7.9%
- Price per share
- $5.28
- Number of holders
- 61
- Value change
- +$12,733,385
- Number of buys
- 34
- Number of sells
- 12
Report period
Q3 2024
Institutions
61
Top holders
10
CRVS full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Corvus Pharmaceuticals, Inc. SEC filings
Corvus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221015100
Recent filing periods:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.6%
|
6,943,654
|
$12,637,450 | — | 30 Jun 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
6.7%
|
6,123,021
|
$11,143,898 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
6.5%
|
5,964,510
|
$10,855,408 | — | 30 Jun 2024 | |
| ADAMS STREET PARTNERS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
3.6%
|
3,275,616
|
$5,961,621 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,650,500
|
$3,003,910 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
563,932
|
$1,026,356 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.62%
|
562,024
|
$1,022,884 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
460,140
|
$837,619 | — | 30 Jun 2024 | |
| TOWERVIEW LLC |
13F
|
Company |
0.44%
|
400,000
|
$728,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.41%
|
371,403
|
$675,954 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
204,598
|
$372,368 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
127,300
|
$231,686 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
120,303
|
$218,951 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
113,400
|
$206,388 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
83,222
|
$151,464 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
82,990
|
$151,042 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
74,559
|
$135,698 | — | 30 Jun 2024 | |
| JACKSON SQUARE CAPITAL, LLC |
13F
|
Company |
0.07%
|
63,773
|
$116,067 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
53,010
|
$96,478 | — | 30 Jun 2024 | |
| Hikari Power Ltd |
13F
|
Company |
0.05%
|
49,959
|
$91,000 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
47,786
|
$86,971 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
25,650
|
$46,683 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
24,364
|
$44,342 | — | 30 Jun 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.02%
|
22,327
|
$40,635 | — | 30 Jun 2024 | |
| COMMERCE BANK |
13F
|
Company |
0.02%
|
20,000
|
$36,400 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.02%
|
18,248
|
$33,211 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
15,668
|
$28,516 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
15,300
|
$27,846 | — | 30 Jun 2024 | |
| OneDigital Investment Advisors LLC |
13F
|
Company |
0.02%
|
14,550
|
$26,481 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
13,000
|
$23,660 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
11,924
|
$21,702 | — | 30 Jun 2024 | |
| AVITY INVESTMENT MANAGEMENT INC. |
13F
|
Company |
0.01%
|
11,580
|
$21,076 | — | 30 Jun 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
11,384
|
$20,719 | — | 30 Jun 2024 | |
| WHITTIER TRUST CO OF NEVADA INC |
13F
|
Company |
0.01%
|
11,200
|
$20,272 | — | 30 Jun 2024 | |
| Masso Torrence Wealth Management Inc. |
13F
|
Company |
0.01%
|
10,000
|
$18,200 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
9,152
|
$16,657 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,238
|
$13,000 | — | 30 Jun 2024 | |
| ROTHSCHILD INVESTMENT LLC |
13F
|
Company |
0.01%
|
7,000
|
$12,740 | — | 30 Jun 2024 | |
| Northwest Capital Management Inc |
13F
|
Company |
0%
|
3,397
|
$6,183 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,212
|
$4,000 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
791
|
$1,439 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
534
|
$971 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
392
|
$713 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
53
|
$96 | — | 30 Jun 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
24
|
$44 | — | 30 Jun 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
20
|
$36 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Jun 2024 | |
| Terry P. Gould |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
3,290,616
mixed-class rows
|
$5,670,746 | — | 13 Jun 2024 | |
| EcoR1 Capital, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
81,077
|
$64,051 | — | 30 Sep 2021 | |
| Edith P. Mitchell |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
— | — | 06 Dec 2023 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q3 2024
As of 30 Sep 2024,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,026,264 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., SAMLYN CAPITAL, LLC, ADAMS STREET PARTNERS LLC, VANGUARD GROUP INC, Vivo Capital, LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Ghost Tree Capital, LLC, and MORGAN STANLEY.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
46
Q3 2024 holders
61
Holder diff
15
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.